Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 21975357)

1.

HIV drug resistance assessment in the Western Pacific region. A systematic review.

Yu D, Sutherland D, Ghidinelli M, Jordan M.

AIDS Rev. 2011 Oct-Dec;13(4):214-26. Review.

PMID:
21975357
2.
3.

Systematic review of HIV drug resistance in Southeast Asia.

Trotter AB, Hong SY, Srikantiah P, Abeyewickreme I, Bertagnolio S, Jordan MR.

AIDS Rev. 2013 Jul-Sep;15(3):162-70. Review.

4.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
5.

Epidemiology of antiretroviral drug resistance in drug-naïve persons.

Geretti AM.

Curr Opin Infect Dis. 2007 Feb;20(1):22-32. Review.

PMID:
17197878
6.

Global HIV drug resistance surveillance.

De Felici A.

Scand J Infect Dis Suppl. 2003;106:21-3. Review.

PMID:
15000577
7.

HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire.

Hanson DL, Adjé-Touré C, Talla-Nzussouo N, Eby P, Borget MY, Kouadio LY, Celestin BE, Tossou O, Eholie S, Kadio A, Chorba T, Nkengasong JN.

AIDS Res Hum Retroviruses. 2009 May;25(5):489-95. doi: 10.1089/aid.2008.0273.

PMID:
19388820
8.

Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options.

De Luca A, Prosperi M, Bracciale L.

Curr Opin HIV AIDS. 2010 Jan;5(1):27-37. doi: 10.1097/COH.0b013e328333ad45. Review.

PMID:
20046145
9.

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.

Aghokeng AF, Kouanfack C, Laurent C, Ebong E, Atem-Tambe A, Butel C, Montavon C, Mpoudi-Ngole E, Delaporte E, Peeters M.

AIDS. 2011 Nov 13;25(17):2183-8. doi: 10.1097/QAD.0b013e32834bbbe9.

PMID:
21860346
10.

Transmitted HIV drug resistance in Asia.

Sohn AH, Srikantiah P, Sungkanuparph S, Zhang F.

Curr Opin HIV AIDS. 2013 Jan;8(1):27-33. doi: 10.1097/COH.0b013e32835b804f. Review.

PMID:
23196932
11.

Antiretroviral drug resistance--implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries.

Obiako OR, Murktar HM, Ogoina D.

Niger J Med. 2010 Oct-Dec;19(4):352-60. Review.

PMID:
21526620
12.

Epidemiological aspects of transmitted HIV drug resistance.

Girardi E.

Scand J Infect Dis Suppl. 2003;106:17-20. Review.

PMID:
15000576
13.

Sequencing of antiretroviral therapy in children in low- and middle-income countries.

Sohn AH, Nuttall JJ, Zhang F.

Curr Opin HIV AIDS. 2010 Jan;5(1):54-60. doi: 10.1097/COH.0b013e3283339bd8. Review.

PMID:
20046148
14.

Current and future management of treatment failure in low- and middle-income countries.

Boyd MA.

Curr Opin HIV AIDS. 2010 Jan;5(1):83-9. doi: 10.1097/COH.0b013e328333b8c0. Review.

PMID:
20046152
15.

Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.

Lihana RW, Lwembe RM, Bi X, Ochieng W, Panikulam A, Palakudy T, Musoke R, Owens M, Ishizaki A, Okoth FA, Songok EM, Ichimura H.

J Clin Virol. 2011 Oct;52(2):123-8. doi: 10.1016/j.jcv.2011.06.014. Epub 2011 Jul 27.

PMID:
21798798
16.
17.

Worldwide transmission of drug-resistant HIV.

Wensing AM, Boucher CA.

AIDS Rev. 2003 Jul-Sep;5(3):140-55. Review.

PMID:
14598563
18.

Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries.

Vergne L, Malonga-Mouellet G, Mistoul I, Mavoungou R, Mansaray H, Peeters M, Delaporte E.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):165-8.

PMID:
11832686
19.

New methods for the surveillance of HIV drug resistance in the resource poor world.

Buckton AJ.

Curr Opin Infect Dis. 2008 Dec;21(6):653-8. doi: 10.1097/QCO.0b013e3283186d1a. Review.

PMID:
18978534
20.

The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.

Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R; PharmAccess African Studies to Evaluate Resistance Programme.

Antivir Ther. 2008;13(5):625-39. Review. Erratum in: Antivir Ther. 2008;13(8):1129.

PMID:
18771046
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk